The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of controlled intratumoral viral delivery of Ad-RTS-hIL-12 + oral veledimex in subjects with recurrent or progressive glioma.
 
Francois M. Lebel
Employment - ZIOPHARM Oncology
Leadership - ZIOPHARM Oncology
Stock and Other Ownership Interests - ZIOPHARM Oncology
 
John A. Barrett
Employment - ZIOPHARM Oncology
Stock and Other Ownership Interests - ZIOPHARM Oncology
 
E. Antonio Chiocca
Honoraria - Merck
Consulting or Advisory Role - Alcyone Lifesciences ; DNAtrix; NanoTX; StemGen; Tocagen
 
John Yu
Employment - ImmunoCellular Therapeutics
Leadership - ImmunoCellular Therapeutics
Stock and Other Ownership Interests - ImmunoCellular Therapeutics
Consulting or Advisory Role - ImmunoCellular Therapeutics
Patents, Royalties, Other Intellectual Property - ImmunoCellular Therapeutics
 
Rimas Vincas Lukas
Consulting or Advisory Role - Novocure
Research Funding - Celldex; VBL Therapeutics; ZIOPHARM Oncology
 
Seema Nagpal
Consulting or Advisory Role - Nektar; Novartis; Novocure; Regeneron
Research Funding - Nektar
 
Priya Kumthekar
No Relationships to Disclose
 
Suma Krishnan
Employment - Intrexon
Leadership - Intrexon
Stock and Other Ownership Interests - Intrexon; ZIOPHARM Oncology
 
Laurence JN Cooper
Employment - ZIOPHARM Oncology
Leadership - ZIOPHARM Oncology
Stock and Other Ownership Interests - Intrexon; ZIOPHARM Oncology
Honoraria - Miltenyi Biotec
Consulting or Advisory Role - Cellectis; immatics
Research Funding - immatics; ZIOPHARM Oncology
Patents, Royalties, Other Intellectual Property - Intrexon; ZIOPHARM Oncology